deanol acetamidobenzoate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

deanol acetamidobenzoate: CNS stimulant; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID Source	ID
PubMed CID	19265
SCHEMBL ID	37892
MeSH ID	M0045932

Synonyms (38)

Synonym
ethanol, 2-(dimethylamino)-, 4-(acetylamino)benzoate (salt)
ethanol, 2-(dimethylamino)-, p-acetamidobenzoate
ethanol, 2-(dimethylamino)-, p-acetamidobenzoate (salt)
dmae p-acetamidobenzoate
einecs 222-858-7
nsc 97399
4-(acetamido)benzoic acid, compound with 2-(dimethylamino)ethanol (1:1)
2-dimethylaminoethanol p-acetamidobenzoate
cervoxan
deanol p-acetamidobenzoate
deaner
nervoton
deanol acetamidobenzoate
diforene
nsc-97399
elevan
3635-74-3
wln: q2n1&1 &ovr dmv1
nsc97399
2-(dimethylamino)ethanol p-acetamidobenzoate
ethanol, p-acetamidobenzoate
2-(dimethylamino)ethanol p-acetylaminobenzoate
D07779
bimanol (tn)
deanol 4-acetamidobenzoate
unii-jsq17gl1cn
jsq17gl1cn ,
deanol acetamidobenzoate [who-dd]
dimethylaminoethyl acetamidobenzoate
deanol acetamidobenzoate [mi]
AKOS025296038
SCHEMBL37892
DTXSID60189880
a-methyl-4-(2-methylpropyl)benzeneacetaldehydeoxime
4-(acetamido)benzoic acid, compound with 2-(dimethylamino)ethanol (1
Q27281679
4-acetamidobenzoic acid;2-(dimethylamino)ethanol
deanol acetaminobenzoate

[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (9)

Timeframe	Studies, This Drug (%)	All Drugs %
pre-1990	9 (100.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.05

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

Metric	This Compound (vs All)
Research Demand Index	12.05 (24.57)
Research Supply Index	2.40 (2.92)
Research Growth Index	4.45 (4.65)
Search Engine Demand Index	10.37 (26.88)
Search Engine Supply Index	0.00 (0.95)

This Compound (12.05)

All Compounds (24.57)

Study Types

Publication Type	This drug (%)	All Drugs (%)
Trials	0 (0.00%)	5.53%
Reviews	0 (0.00%)	6.00%
Case Studies	0 (0.00%)	4.05%
Observational	0 (0.00%)	0.25%
Other	10 (100.00%)	84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Substance	Relationship Strength	Studies	Trials	Classes	Roles
deanol Deanol: An antidepressive agent that has also been used in the treatment of movement disorders. The mechanism of action is not well understood.. N,N-dimethylethanolamine : A tertiary amine that is ethanolamine having two N-methyl substituents.	3.54	9	0	ethanolamines; tertiary amine	curing agent; radical scavenger

Condition	Relationship Strength	Studies
Depression, Endogenous [description not available]	2.34	2
Bodily Distress Disorder [description not available]	1.93	1
Depression Depressive states usually of moderate intensity in contrast with MAJOR DEPRESSIVE DISORDER present in neurotic and psychotic disorders.	2.34	2
Depressive Disorder An affective disorder manifested by either a dysphoric mood or loss of interest or pleasure in usual activities. The mood disturbance is prominent and relatively persistent.	2.34	2
Dementia Praecox [description not available]	2.62	3
Schizophrenia A severe emotional disorder of psychotic depth characteristically marked by a retreat from reality with delusion formation, HALLUCINATIONS, emotional disharmony, and regressive behavior.	2.62	3
Bedwetting [description not available]	1.94	1
Child Behavior Disorders Disturbances considered to be pathological based on age and stage appropriateness, e.g., conduct disturbances and anaclitic depression. This concept does not include psychoneuroses, psychoses, or personality disorders with fixed patterns.	1.94	1
Deficiency, Mental [description not available]	1.94	1
Enuresis Involuntary discharge of URINE after expected age of completed development of urinary control. This can happen during the daytime (DIURNAL ENURESIS) while one is awake or during sleep (NOCTURNAL ENURESIS). Enuresis can be in children or in adults (as persistent primary enuresis and secondary adult-onset enuresis).	1.94	1
Intellectual Disability Subnormal intellectual functioning which originates during the developmental period. This has multiple potential etiologies, including genetic defects and perinatal insults. Intelligence quotient (IQ) scores are commonly used to determine whether an individual has an intellectual disability. IQ scores between 70 and 79 are in the borderline range. Scores below 67 are in the disabled range. (from Joynt, Clinical Neurology, 1992, Ch55, p28)	1.94	1
Nocturnal Enuresis Involuntary discharge of URINE during sleep at night after expected age of completed development of urinary control.	1.94	1
Aura [description not available]	1.93	1
Epilepsy A disorder characterized by recurrent episodes of paroxysmal brain dysfunction due to a sudden, disorderly, and excessive neuronal discharge. Epilepsy classification systems are generally based upon: (1) clinical features of the seizure episodes (e.g., motor seizure), (2) etiology (e.g., post-traumatic), (3) anatomic site of seizure origin (e.g., frontal lobe seizure), (4) tendency to spread to other structures in the brain, and (5) temporal patterns (e.g., nocturnal epilepsy). (From Adams et al., Principles of Neurology, 6th ed, p313)	1.93	1

chemdatabank.com